MYRON INVESTMENTS LIMITED

MYRON INVESTMENTS LIMITED

MYRON INVESTMENTS LIMITED - Company Information

Print Friendly Version

MYRON INVESTMENTS LIMITED

Company Registration Number:
NI004915 (Northern Ireland)

Unaudited abridged accounts for the year ended 05 April 2019

Period of accounts

Start date: 06 April 2018

End date: 05 April 2019

MYRON INVESTMENTS LIMITED

Contents of the Financial Statements

for the Period Ended 05 April 2019

Balance sheet
Notes

MYRON INVESTMENTS LIMITED

Balance sheet

As at 05 April 2019


Notes
2019
2018


£
£
Fixed assets
Investments: 2 4,234 4,234
Total fixed assets: 4,234 4,234
Current assets
Cash at bank and in hand: 1,168,068 1,246,223
Total current assets: 1,168,068 1,246,223
Creditors: amounts falling due within one year:   (87,062) (104,354)
Net current assets (liabilities): 1,081,006 1,141,869
Total assets less current liabilities: 1,085,240 1,146,103
Total net assets (liabilities): 1,085,240 1,146,103
Capital and reserves
Called up share capital: 5,000 5,000
Profit and loss account: 1,080,240 1,141,103
Shareholders funds: 1,085,240 1,146,103

The notes form part of these financial statements

MYRON INVESTMENTS LIMITED

Balance sheet statements

For the year ending 5 April 2019 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 03 January 2020
and signed on behalf of the board by:

Name: S P Henry
Status: Director

The notes form part of these financial statements

MYRON INVESTMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 05 April 2019

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Investment IncomeIncome from listed investments is recognised on the basis of dividends and interest received

Other accounting policies

Investments are stated at costFixed Asset InvestmentsCost At 5 April 2019 £4,234. At 6 April 2018 £4,234.Net Book ValueAt 5 April 2019 £4,234. At 6 April 2018 £4,234.Listed investments comprise:AstraZeneca Group plc 787 Ordinary US$0.25 cost £3,509 market value £48,361Diageo plc 2,903 Ordinary 25p cost £725 market value £90,574Total cost £4,234 market value £138,935

MYRON INVESTMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 05 April 2019

2. Fixed investments

Investments are stated at costFixed Asset InvestmentsCost At 5 April 2019 £4,234. At 6 April 2018 £4,234.Net Book ValueAt 5 April 2019 £4,234. At 6 April 2018 £4,234.Listed investments comprise:AstraZeneca Group plc 787 Ordinary US$0.25 cost £3,509 market value £48,361Diageo plc 2,903 Ordinary 25p cost £725 market value £90,574Total cost £4,234 market value £138,935